2015
Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration
Kueckelhaus M, Fischer S, Seyda M, Bueno E, Aycart M, Alhefzi M, ElKhal A, Pomahac B, Tullius S. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration. Transplant International 2015, 29: 655-662. PMID: 26265179, PMCID: PMC4785085, DOI: 10.1111/tri.12652.Peer-Reviewed Original ResearchConceptsAcute rejectionImproved long-term graft outcomesLong-term graft outcomeChronic allograft deteriorationCytomegalovirus infection statusGraft preservation techniquesUpper extremity transplantationUpper extremity transplantsAntibody-mediated rejectionGood midterm resultsSpecific treatment strategiesAllograft deteriorationChronic rejectionClinical VCAVCA graftsGraft outcomeImmunosuppressive strategiesLocal immunosuppressionMidterm resultsExtremity transplantationCell-based therapiesHLA matchingTolerance inductionTreatment strategiesUS Centers
2011
Perioperative management of partial face transplantation involving a heparin antibody-positive donor
Edrich T, Pomahac B, Lu J, Couper G, Gerner P. Perioperative management of partial face transplantation involving a heparin antibody-positive donor. Journal Of Clinical Anesthesia 2011, 23: 318-321. PMID: 21663819, DOI: 10.1016/j.jclinane.2010.07.004.Peer-Reviewed Original ResearchConceptsMedical historyFace transplantationAntibody-positive donorsPartial face transplantationDonor's medical historyAlternative anticoagulationFull heparinizationSevere strokeImmunologic conditionsPerioperative managementCardiac surgeryPossible complicationsAnesthesia teamTransplantationDonorsAnticoagulationThrombocytopeniaComplicationsThrombosisSurgeryHeparinizationStroke